EMFO LLC’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$279K Buy
3,546
+2,850
+409% +$234K 0.25% 75
2024
Q1
$60.7K Sell
696
-2,250
-76% -$192K 0.06% 144
2023
Q4
$243K Sell
2,946
-250
-8% -$19.1K 0.22% 83
2023
Q3
$250K Buy
3,196
+2,500
+359% +$209K 0.24% 79
2023
Q2
$61.3K Hold
696
0.06% 158
2023
Q1
$56.1K Sell
696
-2,600
-79% -$212K 0.05% 165
2022
Q4
$256K Sell
3,296
-7,500
-69% -$608K 0.26% 71
2022
Q3
$872K Buy
10,796
+10,000
+1,256% +$899K 0.83% 38
2022
Q2
$71K Hold
796
0.07% 159
2022
Q1
$88K Hold
796
0.08% 158
2021
Q4
$82K Sell
796
-1,375
-63% -$159K 0.07% 159
2021
Q3
$272K Sell
2,171
-100
-4% -$12.9K 0.24% 80
2021
Q2
$282K Buy
+2,271
New +$285K 0.25% 82

Other funds holding MDT

EMFO LLC's MDT Position: Q2 2024 in Review

EMFO LLC increased its Medtronic (MDT) stake by 409% in Q2 2024, buying an estimated $234K and bringing the position to 3,546 shares worth $279K. The position accounts for 0.25% of the portfolio, ranked #75.

EMFO LLC first reported a position in MDT in Q2 2021 and has held it in 13 quarters since. The position peaked at $872K in Q3 2022. 2,023 funds tracked by Wall St. Rank hold MDT as of Q2 2024.

  • EMFO LLC held 3,546 shares of Medtronic worth $279K as of Q2 2024.
  • EMFO LLC bought 2,850 Medtronic shares in Q2 2024, an estimated $234K.
  • Medtronic made up 0.25% of EMFO LLC's portfolio in Q2 2024, its #75 holding.
  • EMFO LLC first reported a position in Medtronic in Q2 2021 and has held it in 13 quarters since.
  • EMFO LLC's Medtronic position peaked at $872K in Q3 2022.
  • 2,023 funds tracked by Wall St. Rank held Medtronic as of Q2 2024.

Based on EMFO LLC's 13F filing for Q2 2024, filed 26 Jul 2024.